Patents by Inventor Ann Marie Diederich

Ann Marie Diederich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
    Patent number: 10287280
    Abstract: Disclosed are novel crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide, and solvates thereof and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: May 14, 2019
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Ann Marie Diederich, Robert Herrmann
  • CRYSTALLINE FORMS OF (S)-5-BENZYL-N-(5-METHYL-4-OXO-2,3,4,5-TETRAHYDROBENZO[b][1,4]OXAZEPIN-3-YL)-4H-1,2,4-TRIAZOLE-3-CARBOXAMIDE
    Publication number: 20180022737
    Abstract: Disclosed are novel crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide, and solvates thereof and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof.
    Type: Application
    Filed: February 12, 2016
    Publication date: January 25, 2018
    Inventors: Ann Marie DIEDERICH, Philip Anthony HARRIS, Robert HERRMANN, John KENNA, Lara Kathryn LEISTER
  • Compound, corresponding compositions, preparation and/or treatment methods
    Patent number: 8158645
    Abstract: Disclosed is a novel crystalline form of topotecan monohydrochloride pentahydrate, which is a pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3?,4?:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride, corresponding pharmaceutical compositions, methods preparation and/or use thereof to treat anti-viral and/or cancer-related diseases.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: April 17, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Philip C. Dell'Orco, Ann Marie Diederich, Qiaogong Su, Jeffery Lee Wood
  • NOVEL COMPOUND, CORRESPONDING COMPOSITIONS, PREPARATION AND/OR TREATMENT METHODS
    Publication number: 20100210677
    Abstract: Disclosed is a novel crystalline form of topotecan monohydrochloride pentahydrate, which is a pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3?,4?:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride, corresponding pharmaceutical compositions, methods preparation and/or use thereof to treat anti-viral and/or cancer-related diseases.
    Type: Application
    Filed: April 30, 2010
    Publication date: August 19, 2010
    Inventors: Philip C. DELL'ORCO, Ann Marie Diederich, Qiaogong Su, Jeffery Lee Wood
  • Crystalline topotecan hydrochloride product and process for making the same
    Patent number: 7754733
    Abstract: Disclosed is a novel crystalline form of topotecan monohydrochloride pentahydrate, which is a pentahydrate of 10-[(dimethylamino)methyl]4-ethyl-4,9-dihydroxy-1H-pyrano[3?,4?:6,7]indolizino[1,2-b]quinoline-3,14(4H, 12H)dione monohydrochloride, corresponding pharmaceutical compositions, methods preparation and/or use thereof to treat anti-viral and/or cancer related diseases.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: July 13, 2010
    Assignee: GlaxoSmithKline LLC
    Inventors: Philip C. Dell'orco, Ann Marie Diederich, Qiaogong Su, Jeffery Lee Wood
  • Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
    Patent number: 7750036
    Abstract: The present invention relates to a salt of carvedilol and/or corresponding solvates thereof, compositions containing such carvedilol and/or corresponding solvates thereof, and/or methods of using the aforementioned compound(s) in the treatment of certain disease states in mammals, in particular man. The present invention further relates to carvedilol phosphate salts, and/or solvates thereof, which include a novel crystalline form of carvedilol dihydrogen phosphate (i.e., which is the dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.) and/or other corresponding solvates thereof, compositions containing these carvedilol phosphate salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: July 6, 2010
    Assignee: SB Pharmco Puerto Rico Inc.
    Inventors: Christopher S. Brook, Pingyun Y. Chen, Wei Chen, Qunying Dai, Philip C. Dell'Orco, Clifford S. Labaw, Ann Marie Diederich, Choon K. Oh, Claire Hisler, David H. Igo, Lee M. Katrincic, Li-Jen Ping, Paul G. Spoors, Jun Wang, Christopher Werner
  • Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
    Patent number: 6337408
    Abstract: This invention relates to a method of preparing a compound of the following type by treating a compound of formula (II) with lithium bromide, magnesium bromide and the like.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: January 8, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Andrew Allen, Ann Marie Diederich, Li Liu, Wilford Mendelson, Kevin Webb
  • Method for preparing certain acetonitriles
    Patent number: 6040471
    Abstract: This invention relates to a process for making certain acetonitriles.
    Type: Grant
    Filed: October 15, 1998
    Date of Patent: March 21, 2000
    Assignee: SmithKline Beecham Corporation
    Inventor: Ann Marie Diederich